Selected article for: "acute respiratory distress syndrome and low admission"

Author: Lim, Jeong-Hoon; Park, Sun-Hee; Jeon, Yena; Cho, Jang-Hee; Jung, Hee-Yeon; Choi, Ji-Young; Kim, Chan-Duck; Lee, Yong-Hoon; Seo, Hyewon; Lee, Jaehee; Kwon, Ki Tae; Kim, Shin-Woo; Chang, Hyun-Ha; Kim, Yong-Lim
Title: Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury
  • Cord-id: ez7fcgi2
  • Document date: 2020_6_3
  • ID: ez7fcgi2
    Snippet: The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined accordin
    Document: The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined according to the Acute Kidney Injury Network. Of the 164 hospitalized patients with COVID-19, 30 patients (18.3%) had AKI; 14, 4, and 12 patients had stage 1, 2, and 3, respectively. The median age was significantly higher in AKI patients than in non-AKI patients (75.5 vs. 67.0 years, p = 0.005). There were 17 deaths (56.7%) among AKI patients; 4 (28.6%), 1 (25.0%), and 12 (100.0%), respectively. In-hospital mortality was higher in AKI patients than in non-AKI patients (56.7% vs. 20.8%, p < 0.001). After adjusting for potential confounding factors, stage 3 AKI was associated with higher mortality than either non-AKI or stage 1 AKI (hazard ratio (HR) = 3.62 (95% confidence interval (CI) = 1.75–7.48), p = 0.001; HR = 15.65 (95% CI = 2.43–100.64), p = 0.004). Among the AKI patients, acute respiratory distress syndrome and low serum albumin on admission were considered independent risk factors for stage 3 AKI (both p < 0.05). Five patients with stage 3 AKI underwent dialysis and eventually died. In conclusion, COVID-19 patients with severe AKI had fatal outcomes.

    Search related documents:
    Co phrase search for related documents
    • accompany aki and acute kidney injury: 1
    • accompany aki and acute kidney injury aki: 1
    • acute aki kidney injury and admission albumin: 1, 2
    • acute aki kidney injury and liver function: 1, 2, 3
    • acute aki kidney injury and living center: 1
    • acute ards respiratory distress syndrome and admission albumin: 1, 2
    • acute ards respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and liver function test: 1, 2
    • acute kidney injury aki and admission albumin: 1, 2
    • acute kidney injury aki and liver function: 1, 2, 3
    • acute kidney injury aki and living center: 1
    • acute kidney injury and admission albumin: 1, 2, 3, 4, 5, 6, 7
    • acute kidney injury and admission albumin level: 1
    • acute kidney injury and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute kidney injury and liver function test: 1, 2
    • acute kidney injury and living center: 1
    • acute respiratory distress syndrome and admission symptom onset median duration: 1
    • acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and liver function test: 1, 2